No title
The epidermal growth factor receptor (EGFR) is a receptor involved in cell proliferation. It is frequently overregulated in cancer cells, making it an attractive target for cancer therapeutics. One possible pharmaceutical is protease-X; a protein involved in the cleavage of the EGFR and thus, a way to regulate the receptor’s activity and lead the cancer cells to apoptosis. The aim of this thesis h
